CASGEVY 4 à 13 x 1 000 000 cells/ml, dispersion for infusion
Active ingredients: Exagamglogene autotemcel
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Dispersion for infusion1 ou plusieurs flacons copolymère de cyclooléfines (COC) de 1.5 mL à 20 mL. Spécifique au patient.intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CASGEVY 4 à 13 x 1 000 000 cellules/mL, dispersion pour perfusion
- Pharmaceutical form
- dispersion pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 ou plusieurs flacons copolymère de cyclooléfines (COC) de 1.5 mL à 20 mL. Spécifique au patient.
- Marketing authorisation holder
- VERTEX PHARMACEUTICALS (EUROPE) LIMITED
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 25 Feb 2025
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
66578108CIP75509957CIP133400955099574Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EXAGAMGLOGÈNE AUTOTEMCELdispersion | 4 à 13 × 1 000 000 cellules · 1 mL de dispersion | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.